Annual long term debt:
$29.93B-$3.31B(-9.95%)Summary
- As of today (September 17, 2025), TAK annual long term debt is $29.93 billion, with the most recent change of -$3.31 billion (-9.95%) on March 1, 2025.
- During the last 3 years, TAK annual long term debt has fallen by -$7.58 billion (-20.22%).
- TAK annual long term debt is now -33.86% below its all-time high of $45.24 billion, reached on March 31, 2021.
Performance
TAK Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$28.63B-$1.30B(-4.35%)Summary
- As of today (September 17, 2025), TAK quarterly long term debt is $28.63 billion, with the most recent change of -$1.30 billion (-4.35%) on June 1, 2025.
- Over the past year, TAK quarterly long term debt has dropped by -$2.72 billion (-8.68%).
- TAK quarterly long term debt is now -39.90% below its all-time high of $47.63 billion, reached on June 30, 2019.
Performance
TAK Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TAK Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.9% | -8.7% |
| 3 y3 years | -20.2% | -10.0% |
| 5 y5 years | -33.2% | -31.3% |
TAK Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.2% | at low | -14.6% | at low |
| 5 y | 5-year | -33.9% | at low | -36.7% | at low |
| alltime | all time | -33.9% | >+9999.0% | -39.9% | >+9999.0% |
TAK Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $28.63B(-4.3%) |
| Mar 2025 | $29.93B(-10.0%) | $29.93B(-0.0%) |
| Dec 2024 | - | $29.94B(-3.3%) |
| Sep 2024 | - | $30.95B(-1.3%) |
| Jun 2024 | - | $31.35B(-5.7%) |
| Mar 2024 | $33.23B(-0.9%) | $33.23B(+9.1%) |
| Dec 2023 | - | $30.46B(+3.2%) |
| Sep 2023 | - | $29.51B(-1.5%) |
| Jun 2023 | - | $29.96B(-10.6%) |
| Mar 2023 | $33.53B(-10.6%) | $33.53B(+13.0%) |
| Dec 2022 | - | $29.67B(+3.0%) |
| Sep 2022 | - | $28.80B(-9.4%) |
| Jun 2022 | - | $31.80B(-15.2%) |
| Mar 2022 | $37.51B(-17.1%) | $37.51B(+2.1%) |
| Dec 2021 | - | $36.75B(+2.1%) |
| Sep 2021 | - | $36.00B(-8.8%) |
| Jun 2021 | - | $39.48B(-12.7%) |
| Mar 2021 | $45.24B(+1.0%) | $45.24B(+4.6%) |
| Dec 2020 | - | $43.26B(-1.4%) |
| Sep 2020 | - | $43.89B(+5.4%) |
| Jun 2020 | - | $41.66B(-7.0%) |
| Mar 2020 | $44.79B(+0.3%) | $44.79B(+5.6%) |
| Dec 2019 | - | $42.42B(-5.5%) |
| Sep 2019 | - | $44.91B(-5.7%) |
| Jun 2019 | - | $47.63B(+6.7%) |
| Mar 2019 | $44.66B(+358.2%) | $44.66B(+101.8%) |
| Dec 2018 | - | $22.13B(+185.8%) |
| Sep 2018 | - | $7.74B(-13.7%) |
| Jun 2018 | - | $8.97B(-8.0%) |
| Mar 2018 | $9.75B(+65.4%) | $9.75B(+10.0%) |
| Dec 2017 | - | $8.86B(+0.0%) |
| Sep 2017 | - | $8.86B(+5.8%) |
| Jun 2017 | - | $8.38B(+42.2%) |
| Mar 2017 | $5.89B(+12.2%) | $5.89B(-7.1%) |
| Dec 2016 | - | $6.35B(-13.1%) |
| Sep 2016 | - | $7.31B(+1.3%) |
| Jun 2016 | - | $7.21B(+37.3%) |
| Mar 2016 | $5.25B(-2.4%) | $5.25B(+0.3%) |
| Dec 2015 | - | $5.24B(-0.3%) |
| Sep 2015 | - | $5.25B(+1.5%) |
| Jun 2015 | - | $5.17B(-3.9%) |
| Mar 2015 | $5.38B(-22.9%) | $5.38B(-11.7%) |
| Dec 2014 | - | $6.10B(-6.4%) |
| Sep 2014 | - | $6.52B(-18.5%) |
| Jun 2014 | - | $7.99B(+22.8%) |
| Mar 2014 | $6.98B | $6.51B(-13.4%) |
| Dec 2013 | - | $7.52B(-6.6%) |
| Sep 2013 | - | $8.05B(+48.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $5.44B(-8.1%) |
| Mar 2013 | $5.91B(+53.1%) | $5.91B(-5.3%) |
| Dec 2012 | - | $6.25B(-10.0%) |
| Sep 2012 | - | $6.94B(+83.9%) |
| Jun 2012 | - | $3.78B(-2.2%) |
| Mar 2012 | $3.86B(+1853.5%) | $3.86B(>+9900.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | $197.72M(+18.9%) | $197.72M(>+9900.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sep 2010 | - | $0.00(-100.0%) |
| Mar 2010 | $166.24M(-7.8%) | $166.24M(>+9900.0%) |
| Dec 2009 | - | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | $180.22M(+1335.0%) | $0.00(0.0%) |
| Dec 2008 | - | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | $12.56M(-27.7%) | - |
| Mar 2008 | - | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Mar 2007 | $17.36M(-41.0%) | - |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Mar 2006 | $29.43M(-43.4%) | - |
| Mar 2006 | - | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Mar 2005 | $51.99M(+16.0%) | - |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | - | $0.00 |
| Mar 2004 | $44.80M(+9.1%) | - |
| Mar 2003 | $41.05M(-9.2%) | - |
| Mar 2002 | $45.21M(-4.3%) | - |
| Mar 2001 | $47.26M(-31.7%) | - |
| Mar 2000 | $69.16M(-16.9%) | - |
| Mar 1999 | $83.20M(+1.8%) | - |
| Mar 1998 | $81.71M(-75.1%) | - |
| Mar 1997 | $328.76M(-18.3%) | - |
| Mar 1996 | $402.28M(-26.2%) | - |
| Mar 1995 | $544.81M(+49.2%) | - |
| Mar 1994 | $365.09M(-17.2%) | - |
| Mar 1993 | $440.81M(+12.9%) | - |
| Mar 1992 | $390.44M(+28.2%) | - |
| Mar 1991 | $304.67M | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual long term debt?
- What is the all time high annual long term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual long term debt year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly long term debt?
- What is the all time high quarterly long term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly long term debt year-on-year change?
What is Takeda Pharmaceutical Company Limited annual long term debt?
The current annual long term debt of TAK is $29.93B
What is the all time high annual long term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual long term debt is $45.24B
What is Takeda Pharmaceutical Company Limited annual long term debt year-on-year change?
Over the past year, TAK annual long term debt has changed by -$3.31B (-9.95%)
What is Takeda Pharmaceutical Company Limited quarterly long term debt?
The current quarterly long term debt of TAK is $28.63B
What is the all time high quarterly long term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly long term debt is $47.63B
What is Takeda Pharmaceutical Company Limited quarterly long term debt year-on-year change?
Over the past year, TAK quarterly long term debt has changed by -$2.72B (-8.68%)